✅ New API: 6000+ US Stock Options End-of-Day Data with 40+ fields. Learn more

Passage Bio Inc (PASG NASDAQ) stock market data APIs

$6.9552 0.08(1.2%)
as of September 12, 2025
Try our APIs with free plan!

Passage Bio Inc Financial Data Overview

Price chart is built with Anychart
OpenFigi: BBG00NBK**** The data is available with plans that include the Fundamentals API. Check our pricing page for details. CIK: 000178**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.

Prev. Close 6.9552
Open 7.0323
High 7.2593
Low 6.825
52 wk Range 5.1239-26.6
Market Cap 22 251 K
P/E Ratio 0.1777
Shares Outstanding 3 179 K
EPS -2.96
Beta 1.824

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Passage Bio Inc (top by weight)

Ticker
100-day Price Change
Weight
IS0R.F iShares High Yield Corporate Bond UCITS
1.01 (1.23%)
0.03
IS0R.XETRA iShares $ High Yield Corp Bond UCITS ETF USD (Dist) EUR
1.07 (1.3%)
0.03

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Passage Bio Inc data using free add-ons & libraries


Get Passage Bio Inc Fundamental Data

Passage Bio Inc Fundamental data includes:

  • Net Revenue:
  • EBITDA: -52 485 000
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Passage Bio Inc Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-07-31
  • EPS/Forecast: -0.202
GET THE PACKAGE

Get Passage Bio Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Passage Bio Inc News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat